Zebra Medical Vision set to bring AI to orthopedic care

Zebra Medical Vision has announced a new collaboration with DePuy Ireland Unlimited Company, agreeing to deploy cloud-based AI solutions focused on orthopedic care.

As a result of this new arrangement, DePuy Synthes companies will now have access Zebra Medical Vision’s AI algorithms, which “bring affordable pre-operative surgical planning to surgeons worldwide without the need for traditional MRI or CT-based imaging.” The technology will impact pre-operative, operative and post-operative patient care.

“We are thrilled to start this collaboration and have the opportunity to impact and improve orthopedic procedures and outcomes in areas including the knee, hip, shoulder, trauma, and spine care,” Eyal Gura, co-founder and CEO of Zebra Medical Vision, said in a prepared statement. “We share a common vision surrounding the impact we can have on patients’ lives through the use of AI, and we are happy to initiate such a meaningful strategic partnership, leveraging the tools and knowledge we have built around bone health AI in the last five years.” 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.